Comment on "Second-Generation Tyrosine Kinase Inhibitors Improve the Survival of Patients With Chronic Myeloid Leukemia in Whom Imatinib Therapy Has Failed" Haematologica 2011;96(12):1779-82
Haematologica - Italy
doi 10.3324/haematol.2011.061630
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2012
Authors
Publisher
Ferrata Storti Foundation (Haematologica)